B cells could play key role in new AIDS vax

Researchers at Duke University have offered up a key insight that could help researchers develop a new AIDS vaccine. They found that the immune system is quick to eliminate critical B cells that the body could use to fight off the virus that causes AIDS. Finding a pathway around that obstacle, so that the B cells can do their work, would be a big step toward the development of an effective vaccine.

"This work may mean that we need to think and act very differently in envisioning how a successful vaccine may work," says study author Laurent Verkoczy, an assistant professor of medicine at Duke University Medical Center.

The team reached its conclusion after creating a new mouse model that was able to produce high levels of B cells containing a potent antibody that could block HIV infections. But their immune systems eradicated most of the cells before they could mature.

- here's the Duke release
- check out the story from HealthDay

Suggested Articles

The countdown to the FDA's first coronavirus vaccine hearing has begun, and new agency documents outline an agenda for the Thursday confab.

Dr. Anthony Fauci will oversee most of the ongoing COVID-19 vaccine trials in the U.S., save for Pfizer's, ProPublica reports.

COVID vaccine and drug trial pauses show that the system is working as intended to verify safety and efficacy, the FDA commissioner told Bloomberg.